应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03692 翰森制药
已收盘 02-25 16:08:35
34.600
-0.020
-0.06%
最高
35.300
最低
34.520
成交量
538.49万
今开
35.140
昨收
34.620
日振幅
2.25%
总市值
2,095亿
流通市值
2,095亿
总股本
60.55亿
成交额
1.87亿
换手率
0.09%
流通股本
60.55亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 翰森制药 02月24日卖空量成交106.2万股,卖空比例为10.55%
市场透视 · 02-24 16:30
每日卖空追踪 | 翰森制药 02月24日卖空量成交106.2万股,卖空比例为10.55%
港股三大指数早盘集体受压 恒指半日跌1.93% 翰森制药跌6.49%
金吾资讯 · 02-24 12:16
港股三大指数早盘集体受压 恒指半日跌1.93% 翰森制药跌6.49%
大公司创新情报(2月21日):翰森制药:甲磺酸阿美替尼片单药治疗于欧盟获批上市
亿欧 · 02-21
大公司创新情报(2月21日):翰森制药:甲磺酸阿美替尼片单药治疗于欧盟获批上市
翰森制药肺癌新药欧盟获批上市!
摩熵医药 · 02-21
翰森制药肺癌新药欧盟获批上市!
港股公告掘金 | 英硅智能、图达通及长风药业获纳入恒生综合指数成份股
智通财经 · 02-20
港股公告掘金 | 英硅智能、图达通及长风药业获纳入恒生综合指数成份股
翰森制药(03692):甲磺酸阿美替尼片单药治疗于欧盟获批上市
智通财经 · 02-20
翰森制药(03692):甲磺酸阿美替尼片单药治疗于欧盟获批上市
每日卖空追踪 | 翰森制药 02月16日卖空量成交57.4万股,卖空比例为24.1%
市场透视 · 02-16
每日卖空追踪 | 翰森制药 02月16日卖空量成交57.4万股,卖空比例为24.1%
翰森制药02月16日获主力加仓212.0万元
市场透视 · 02-16
翰森制药02月16日获主力加仓212.0万元
每日卖空追踪 | 翰森制药 02月10日卖空量成交188.6万股,卖空比例为21.98%
市场透视 · 02-10
每日卖空追踪 | 翰森制药 02月10日卖空量成交188.6万股,卖空比例为21.98%
翰森制药02月10日获主力加仓1283.1万元
市场透视 · 02-10
翰森制药02月10日获主力加仓1283.1万元
创新药概念震荡反弹 高增长潜力概念股出炉
腾讯自选股综合 · 02-10
创新药概念震荡反弹 高增长潜力概念股出炉
每日卖空追踪 | 翰森制药 02月09日卖空量成交174万股,卖空比例为17.12%
市场透视 · 02-09
每日卖空追踪 | 翰森制药 02月09日卖空量成交174万股,卖空比例为17.12%
翰森制药02月09日获主力加仓2636.5万元
市场透视 · 02-09
翰森制药02月09日获主力加仓2636.5万元
高盛:今年内地医疗板块更依赖数据及盈利能见度 看好CDMO企业
智通财经 · 02-09
高盛:今年内地医疗板块更依赖数据及盈利能见度 看好CDMO企业
医药行业周报:分子胶:撬动“不可成药”靶点的创新药新范式
华源证券 · 02-09
医药行业周报:分子胶:撬动“不可成药”靶点的创新药新范式
每日卖空追踪 | 翰森制药 02月04日卖空量成交53万股,卖空比例为7.08%
市场透视 · 02-04
每日卖空追踪 | 翰森制药 02月04日卖空量成交53万股,卖空比例为7.08%
翰森制药:46.8亿港元零息可换股债券发行完成 款项将2031年前悉数动用
财中社 · 02-03
翰森制药:46.8亿港元零息可换股债券发行完成 款项将2031年前悉数动用
翰森制药集团有限公司发布2026年1月法定/注册股本及已发行股份变动月报表
金吾财讯 · 02-03
翰森制药集团有限公司发布2026年1月法定/注册股本及已发行股份变动月报表
翰森制药(03692)2026年1月股份变动月报:股本维持不变
公告速递 · 02-03
翰森制药(03692)2026年1月股份变动月报:股本维持不变
瞩目,豪森药业重磅1类新药迎来新进展
北京药研汇 · 02-03
瞩目,豪森药业重磅1类新药迎来新进展
公司概况
公司名称:
翰森制药
所属市场:
SEHK
上市日期:
--
主营业务:
翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。该公司的创新药产品包括阿美乐、豪森昕福、迈灵达、孚来美、恒沐、昕越、圣罗莱等产品。该公司的创新药产品主要应用于抗肿瘤、抗感染、中枢神经系统(CNS)疾病、代谢及其他治疗领域。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"03692","market":"HK","secType":"STK","nameCN":"翰森制药","latestPrice":34.6,"timestamp":1772006915007,"preClose":34.62,"halted":0,"volume":5384897,"delay":0,"changeRate":-0.0005777007510108615,"floatShares":6055000000,"shares":6055000000,"eps":0.8401908794400563,"marketStatus":"已收盘","change":-0.02,"latestTime":"02-25 16:08:35","open":35.14,"high":35.3,"low":34.52,"amount":187188284,"amplitude":0.02253,"askPrice":34.6,"askSize":10000,"bidPrice":34.58,"bidSize":4000,"shortable":3,"etf":0,"ttmEps":0.9151500842339877,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1772069400000},"marketStatusCode":5,"adr":0,"listingDate":1560441600000,"exchange":"SEHK","adjPreClose":34.62,"dividendRate":0.010604,"openAndCloseTimeList":[[1771983000000,1771992000000],[1771995600000,1772006400000]],"volumeRatio":0.75793,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03692/wiki","defaultTab":"wiki","newsList":[{"id":"2614722265","title":"每日卖空追踪 | 翰森制药 02月24日卖空量成交106.2万股,卖空比例为10.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614722265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614722265?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:30","pubTimestamp":1771921833,"startTime":"0","endTime":"0","summary":"翰森制药北京时间02月24日,跌6.43%,卖空量成交106.2万股,较上一交易日减少24.68%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163539a7191d96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224163539a7191d96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03692","BK1589","BK1583"],"gpt_icon":0},{"id":"2613765081","title":"港股三大指数早盘集体受压 恒指半日跌1.93% 翰森制药跌6.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2613765081","media":"金吾资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613765081?lang=zh_cn&edition=full","pubTime":"2026-02-24 12:16","pubTimestamp":1771906614,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股三大指数早盘集体受压,截至午间收盘,恒指跌1.93%,恒科指跌2.36%,国企指跌2.06%。建滔集团预期截至2025年12月31日止年度录得的纯利较2024年同期上升超过165%,即纯利超过43.2亿港元。截至2月16日,港股市场仍有401宗新股申请仍在处理之中,包括4家已通过聆讯的企业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224121707a4c1563b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224121707a4c1563b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01888","03692","HSTECH","KBDCY","BK4614","HSI","00148","BK4585","BK4588"],"gpt_icon":0},{"id":"2613122360","title":"大公司创新情报(2月21日):翰森制药:甲磺酸阿美替尼片单药治疗于欧盟获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2613122360","media":"亿欧","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613122360?lang=zh_cn&edition=full","pubTime":"2026-02-21 17:37","pubTimestamp":1771666624,"startTime":"0","endTime":"0","summary":"今日看点翰森制药:甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密港股IPO招股书失效今日情报翰森制药翰森制药:甲磺酸阿美替尼片单药治疗于欧盟获批上市立讯精密立讯精密港股IPO招股书失效回顾2月20日大公司创新情报,请点击 大公司创新情报:五粮液:公司暂无设立投资公司计划,资金以服务主业为核心大公司创新情报是亿欧数据推出的一款信息服务产品,为您网罗国内知名大公司的创新动态,持续追踪各领域的新技术新模式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221173952a70fe885&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221173952a70fe885&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0},{"id":"2613422367","title":"翰森制药肺癌新药欧盟获批上市!","url":"https://stock-news.laohu8.com/highlight/detail?id=2613422367","media":"摩熵医药","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2613422367?lang=zh_cn&edition=full","pubTime":"2026-02-21 12:51","pubTimestamp":1771649460,"startTime":"0","endTime":"0","summary":"2月20日,翰森制药宣布,创新药甲磺酸阿美替尼片单药治疗已正式获得欧盟委员会批准在欧盟上市,用于:具有表皮生长因子受体外显子19缺失或外显子21置换突变的晚期非小细胞肺癌成人患者的一线治疗;晚期EGFR T790M突变阳性NSCLC成人患者的治疗。作为翰森制药自主研发的三代EGFR-TKI,甲磺酸阿美替尼具有良好的脂溶性和稳定性,能更好地透过血脑屏障,且不良反应发生率低。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221213027a7106237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260221213027a7106237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","BK1583","BK1191","BK1589"],"gpt_icon":0},{"id":"2612237504","title":"港股公告掘金 | 英硅智能、图达通及长风药业获纳入恒生综合指数成份股","url":"https://stock-news.laohu8.com/highlight/detail?id=2612237504","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612237504?lang=zh_cn&edition=full","pubTime":"2026-02-20 09:15","pubTimestamp":1771550100,"startTime":"0","endTime":"0","summary":"【重大事项】英硅智能(03696)获纳入恒生综合指数成份股图达通(02665)获纳入恒生综合指数成份股长风药业(02652)获纳入恒生综合指数成份股翰森制药(03692):甲磺酸阿美替尼片单药治疗于欧盟获批上市拨康视云-B(02592):CBT-199新药临床试验申请已生效,临床试验被认定为可安全推进石药集团(01093):GLP -1/GIP受体双偏向性激动多肽长效注射液在美国获临床试验批准石药","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02498","03696","BK1179","BK4585","VXUS","03692","BK4588","VT","02665","HSCI","BK1191","BK1144","BK1589","BK1141","BK1583","02652"],"gpt_icon":0},{"id":"2612231679","title":"翰森制药(03692):甲磺酸阿美替尼片单药治疗于欧盟获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2612231679","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612231679?lang=zh_cn&edition=full","pubTime":"2026-02-20 07:01","pubTimestamp":1771542116,"startTime":"0","endTime":"0","summary":"智通财经APP讯,翰森制药(03692)公布,于2026年2月12日,集团创新药甲磺酸阿美替尼片(中国商品名:阿美乐®,海外商品名:Aumseqa®)单药治疗已于欧盟获批上市,用于:(i)具有表皮生长因子受体(EGFR)外显子19缺失或外显子21(L858R) 置换突变的晚期非小细胞肺癌(NSCLC)成人患者的一线治疗,以及(ii)晚期 EGFR T790M突变阳性NSCLC成人患者的治疗。此次批准由欧盟委员会(EC)基于欧洲药品管理局(EMA)人用药品委员会(CHMP)的积极意见作出。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1405929.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1583","FSXEmain","BK1589","FESXmain","03692"],"gpt_icon":0},{"id":"2612238439","title":"每日卖空追踪 | 翰森制药 02月16日卖空量成交57.4万股,卖空比例为24.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2612238439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612238439?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:30","pubTimestamp":1771230631,"startTime":"0","endTime":"0","summary":"翰森制药北京时间02月16日,涨1.65%,卖空量成交57.4万股,较上一交易日减少62.04%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163433a4a9f833&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216163433a4a9f833&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","03692","BK1583"],"gpt_icon":0},{"id":"2611037101","title":"翰森制药02月16日获主力加仓212.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611037101","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611037101?lang=zh_cn&edition=full","pubTime":"2026-02-16 16:15","pubTimestamp":1771229732,"startTime":"0","endTime":"0","summary":"02月16日, 翰森制药股价涨1.65%,报收36.90元,成交金额8739.9万元,换手率0.04%,振幅5.07%,量比0.30。翰森制药今日主力资金净流入212.0万元,上一交易日主力净流入392.3万元。该股近5个交易日下跌0.59%,主力资金累计净流入2378.0万元;近20日主力资金累计净流入1.1亿元,其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161659a700d49f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260216161659a700d49f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1191","03692","BK1589"],"gpt_icon":0},{"id":"2610641845","title":"每日卖空追踪 | 翰森制药 02月10日卖空量成交188.6万股,卖空比例为21.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610641845","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610641845?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:30","pubTimestamp":1770712237,"startTime":"0","endTime":"0","summary":"翰森制药北京时间02月10日,涨1.13%,卖空量成交188.6万股,较上一交易日减少55.22%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163529a6e9af16&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210163529a6e9af16&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1589","03692","BK1191"],"gpt_icon":0},{"id":"2610464184","title":"翰森制药02月10日获主力加仓1283.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610464184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610464184?lang=zh_cn&edition=full","pubTime":"2026-02-10 16:15","pubTimestamp":1770711359,"startTime":"0","endTime":"0","summary":"02月10日, 翰森制药股价涨1.13%,报收37.54元,成交金额3.7亿元,换手率0.16%,振幅2.59%,量比1.09。翰森制药今日主力资金净流入1283.1万元,连续7日净流入,上一交易日主力净流入2636.5万元。近一年数据显示,该股主力连续7日净流入后,次日上涨概率为44.44%,平均涨幅为2.61%。该股近5个交易日上涨5.13%,主力资金累计净流入5030.1万元,其中3个交易日为股价下跌时净流入;近20日主力资金累计净流入1.0亿元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162155a492aaa6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260210162155a492aaa6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1589","BK1191","03692"],"gpt_icon":0},{"id":"2610969486","title":"创新药概念震荡反弹 高增长潜力概念股出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2610969486","media":"腾讯自选股综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610969486?lang=zh_cn&edition=full","pubTime":"2026-02-10 11:17","pubTimestamp":1770693474,"startTime":"0","endTime":"0","summary":"创新药概念盘中震荡反弹,广生堂涨超10%,此前万邦德涨停,尖峰集团、信立泰、北陆药业、荣昌生物、首药控股等多股涨超5%。华源证券指出,经历短期波动消化后,创新药板块已显现企稳回暖迹象。整体上,国金证券认为创新药前期回调较为充分,向上产业趋势明确,催化近期密集,继续看好板块投资机会。从未来增长潜力来看,多股获机构预测2026年净利增速有望翻倍。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026021010545497a590eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["00867","02196","00013","01548","BK1161","02096","01276","01877","BK1574","06978","02269","01177","01093","02228","03692","BK1583","01952","01513","BK1515","00512","06185","06160","01801"],"gpt_icon":0},{"id":"2610066708","title":"每日卖空追踪 | 翰森制药 02月09日卖空量成交174万股,卖空比例为17.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610066708","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610066708?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:30","pubTimestamp":1770625835,"startTime":"0","endTime":"0","summary":"翰森制药北京时间02月09日,涨1.75%,卖空量成交174万股,较上一交易日减少34.09%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163953a6e55242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209163953a6e55242&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03692","BK1589","BK1583"],"gpt_icon":0},{"id":"2610651224","title":"翰森制药02月09日获主力加仓2636.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610651224","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610651224?lang=zh_cn&edition=full","pubTime":"2026-02-09 16:15","pubTimestamp":1770624947,"startTime":"0","endTime":"0","summary":"02月09日, 翰森制药股价涨1.75%,报收37.12元,成交金额3.8亿元,换手率0.17%,振幅2.25%,量比1.19。翰森制药今日主力资金净流入2636.5万元,连续6日净流入,上一交易日主力净流入195.9万元。近一年数据显示,该股主力连续6日净流入后,次日上涨概率为55.56%,平均涨幅为2.33%。该股近5个交易日上涨4.17%,主力资金累计净流入4320.7万元,其中3个交易日为股价下跌时净流入;近20日主力资金累计净流入9414.5万元,其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162212a6e53cb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209162212a6e53cb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1589","BK1583","03692"],"gpt_icon":0},{"id":"2610568695","title":"高盛:今年内地医疗板块更依赖数据及盈利能见度 看好CDMO企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2610568695","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610568695?lang=zh_cn&edition=full","pubTime":"2026-02-09 14:08","pubTimestamp":1770617323,"startTime":"0","endTime":"0","summary":"今年要获得超越行业的回报,更依赖于关键数据公布、实际成交,以及盈利兑现或转折点的能见度。该行对医疗器械板块维持中性看法,虽然行业已触底,但需时逐步复苏;推荐买时代天使及威高股份。医疗服务板块方面,该行仍持相对谨慎态度,因成本控制措施的持续影响,以及疲弱的消费周期;下调海吉亚医疗评级至“中性”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1403066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2045819591.USD","LU0196878994.USD","HK0000165453.HKD","BK1589","LU2125910500.SGD","06990","02359","LU2488822045.USD","BK1583","CDMO","BK4139","SG9999014674.SGD","LU0708995583.HKD","BK1141","03692","LU0052750758.USD","02268","BK1576","BK1161","159891","HK0000320264.USD","HK0000306685.HKD","02696","LU2242644610.SGD","HK0000306701.USD","HK0000320223.HKD","LU1046422090.SGD","BK1191","LU0320764599.SGD"],"gpt_icon":0},{"id":"2610782651","title":"医药行业周报:分子胶:撬动“不可成药”靶点的创新药新范式","url":"https://stock-news.laohu8.com/highlight/detail?id=2610782651","media":"华源证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610782651?lang=zh_cn&edition=full","pubTime":"2026-02-09 00:00","pubTimestamp":1770566400,"startTime":"0","endTime":"0","summary":"另外,经历短期波动消化后,创新药板块已显现企稳回暖迹象。分子胶拓展难成药靶点空间,建议关注苑东生物相关药物进展。在仅约700 个蛋白被证实具有成药性、FDA 获批靶点仅约532 个,而仍有3000 余个与疾病、密切相关的“难成药靶点”尚未被药物有效覆盖。分子胶通过E3 泛素连接酶介导的靶向蛋白降解,为“不可成药靶点”提供了系统性成药路径,显著扩展创新药靶点空间,或是中长期最具想象力的技术方向之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209200153a48f1fa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260209200153a48f1fa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1583","BK1191","03692","BK1589","06978","BK1161"],"gpt_icon":0},{"id":"2609311275","title":"每日卖空追踪 | 翰森制药 02月04日卖空量成交53万股,卖空比例为7.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2609311275","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609311275?lang=zh_cn&edition=full","pubTime":"2026-02-04 16:30","pubTimestamp":1770193834,"startTime":"0","endTime":"0","summary":"翰森制药北京时间02月04日,跌1.55%,卖空量成交53万股,较上一交易日减少75.91%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163745a6d205a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204163745a6d205a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1589","BK1191","03692"],"gpt_icon":0},{"id":"2608765118","title":"翰森制药:46.8亿港元零息可换股债券发行完成 款项将2031年前悉数动用","url":"https://stock-news.laohu8.com/highlight/detail?id=2608765118","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608765118?lang=zh_cn&edition=full","pubTime":"2026-02-03 20:31","pubTimestamp":1770121893,"startTime":"0","endTime":"0","summary":"翰森制药(03692)发布公告,完成发行46.8亿港元于2033年到期的零息可换股债券。董事会宣布,认购协议所载发行债券的所有先决条件均已达成,且发行债券已于2026年2月3日成功落实。债券预计将于2026年2月4日或前后获准于维也纳证券交易所上市及交易。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602033640341349.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03692","BK1589","BK1191","BK1583"],"gpt_icon":0},{"id":"2608482062","title":"翰森制药集团有限公司发布2026年1月法定/注册股本及已发行股份变动月报表","url":"https://stock-news.laohu8.com/highlight/detail?id=2608482062","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608482062?lang=zh_cn&edition=full","pubTime":"2026-02-03 17:50","pubTimestamp":1770112201,"startTime":"0","endTime":"0","summary":"在法定/注册股本方面,截至2026年1月31日,翰森制药的法定/注册股份数目为20,000,000,000股,面值为每股0.00001港元,总金额为200,000港元。与上月底相比,法定/注册股本未发生任何变动。此外,关于可换股票据,翰森制药于2021年1月22日发行的、将于2026年到期的零息可换股债券已到期。综上所述,翰森制药集团有限公司在2026年1月的法定/注册股本及已发行股份均未发生变动,且已完全符合相关公众持股量要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203181342a47726f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203181342a47726f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1589","BK1191","03692"],"gpt_icon":0},{"id":"1165763550","title":"翰森制药(03692)2026年1月股份变动月报:股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1165763550","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165763550?lang=zh_cn&edition=full","pubTime":"2026-02-03 17:14","pubTimestamp":1770110066,"startTime":"0","endTime":"0","summary":"翰森制药集团有限公司于2026年2月3日公告的截至2026年1月31日股份变动月报显示,公司在本月内股本结构没有发生变化,整体股本维持稳定。至1月末,已发行股份总数为6,055,150,070股,与上月底相同,期间无新增发行、购回或注销股份,亦无库藏股份变动。截至1月末,公司符合香港联交所关于最低公众持股量的相关要求。本月报由联席公司秘书钟胜利女士签署。公司确认其遵守香港联交所上市规则及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03692"],"gpt_icon":0},{"id":"2608582061","title":"瞩目,豪森药业重磅1类新药迎来新进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2608582061","media":"北京药研汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608582061?lang=zh_cn&edition=full","pubTime":"2026-02-03 08:03","pubTimestamp":1770077033,"startTime":"0","endTime":"0","summary":"2026年2月2日,据中国国家药品审评中心官网显示,江苏豪森药业集团有限公司申报的1类新药HS-10390片新适应症临床试验申请获默示许可。2023年1月9日,翰森制药附属公司常州恒邦药业有限公司及上海翰森生物医药科技有限公司自主研发的1类新药\"HS-10390片\"首次获得临床试验批准,拟用于治疗局灶节段性肾小球硬化和免疫球蛋白A肾病。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203083100a6cbf7b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260203083100a6cbf7b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0618},{"period":"1month","weight":-0.1341},{"period":"3month","weight":-0.1452},{"period":"6month","weight":-0.0243},{"period":"1year","weight":0.8425},{"period":"ytd","weight":-0.0405}],"compareEarnings":[{"period":"1week","weight":-0.0043},{"period":"1month","weight":-0.006},{"period":"3month","weight":0.0255},{"period":"6month","weight":0.0637},{"period":"1year","weight":0.1392},{"period":"ytd","weight":0.0374}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"翰森制药集团有限公司是一家主要从事一系列药品的研发、生产及销售的投资控股公司。该公司的创新药产品包括阿美乐、豪森昕福、迈灵达、孚来美、恒沐、昕越、圣罗莱等产品。该公司的创新药产品主要应用于抗肿瘤、抗感染、中枢神经系统(CNS)疾病、代谢及其他治疗领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":-0.002565},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.014078},{"month":3,"riseRate":0.333333,"avgChangeRate":0.024785},{"month":4,"riseRate":0.5,"avgChangeRate":0.03201},{"month":5,"riseRate":0.666667,"avgChangeRate":0.019349},{"month":6,"riseRate":0.666667,"avgChangeRate":0.055622},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.000332},{"month":8,"riseRate":0.714286,"avgChangeRate":0.01897},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.033021},{"month":10,"riseRate":0.142857,"avgChangeRate":0.001586},{"month":11,"riseRate":0.714286,"avgChangeRate":0.063467},{"month":12,"riseRate":0.571429,"avgChangeRate":0.016858}],"exchange":"SEHK","name":"翰森制药","nameEN":"HANSOH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"翰森制药,03692,翰森制药股票,翰森制药股票老虎,翰森制药股票老虎国际,翰森制药行情,翰森制药股票行情,翰森制药股价,翰森制药股市,翰森制药股票价格,翰森制药股票交易,翰森制药股票购买,翰森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"翰森制药(03692)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供翰森制药(03692)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}